Skip to main content

Inozyme Pharma, Inc.

INZYDelisted Jul 1, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001693011

Inozyme Pharma, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 3, 2025; 87 institutions reported holding it in 13F filings for Q2 2025, worth $202.3M in total; no superinvestor held it.

Members of Congress who traded INZY

No member of Congress has reported a trade in Inozyme Pharma, Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.